Shanehsaz SM, Ishkhanian S. Electrocardiographic and biochemical adverse effects of meglumine antimoniate (MA) during treatment of Syrian cutaneous leishmaniasis patients. J Pak Assoc Dermatol [Internet]. 2016Dec.16 [cited 2026Feb.26];23(4):412-7. Available from: https://www.jpad.com.pk/index.php/jpad/article/view/289